Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study

Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials

(2013) Arjen Joosse et al.   JOURNAL OF CLINICAL ONCOLOGY

Nivolumab plus Ipilimumab in Advanced Melanoma

(2013) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Use in Relation to Prostate Cancer Outcomes in a Population-based Patient Cohort Study

(2013) Milan S. Geybels et al.   PROSTATE

Statins Reduce Melanoma Development and Metastasis through MICA Overexpression

(2013) Christine Pich et al.   Frontiers in Immunology

Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative

(2012) Deepa Jagtap et al.   CANCER

Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials

(2012) Arjen Joosse et al.   JOURNAL OF CLINICAL ONCOLOGY

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

(2012) Michael Krauthammer et al.   NATURE GENETICS

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Use and Reduced Cancer-Related Mortality

(2012) Sune F. Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sex Disparities in Cancer Mortality and Survival

(2011) M. B. Cook et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

(2011) T. P. Ahern et al.   JNCI-Journal of the National Cancer Institute

Simvastatin impairs murine melanoma growth

(2011) Giovani M Favero et al.   Lipids in Health and Disease

Statin use and cancer risk: a comprehensive review

(2010) Denise M Boudreau et al.   Expert Opinion On Drug Safety

Prevalence and determinants of pharmacy shopping behaviour

(2010) H. Buurma et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway

(2010) Yasuhiro Kidera et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells

(2010) Guillaume Sarrabayrouse et al.   PLoS One

Autocrine amplification loop in statin-induced apoptosis of human melanoma cells

(2009) C Minichsdorfer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Targeting the Mevalonate Pathway for Improved Anticancer Therapy

(2009) G. Fritz   CURRENT CANCER DRUG TARGETS

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

(2009) Myrthe P.P. van Herk-Sukel et al.   EUROPEAN JOURNAL OF CANCER

Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials

(2009) Stefanos Bonovas et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells

(2009) Akira Saito et al.   MELANOMA RESEARCH

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

(2008) Sharon A Glynn et al.   BMC CANCER

Brick by brick: metabolism and tumor cell growth

(2008) Ralph J DeBerardinis et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY